<DOC>
	<DOC>NCT02028286</DOC>
	<brief_summary>The purpose of this study is to characterize the pharmacokinetics of once daily topical gel and confirm that steady state conditions are reached under maximal use conditions following 3 weeks of daily applications.</brief_summary>
	<brief_title>A 21 Day Pharmacokinetics Study in Papulopustular Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<criteria>A diagnosis of papulopustular rosacea Grade 3 or 4 on the 5point Investigator Global Assessment scale Presence of telangiectasia steroid rosacea or subtype 3 (phymatous rosacea) clinically significant abnormal findings that would interfere with study objective or risk to safety for the subject. nodular rosacea (lesions greater than 5mm with more than 2 modules)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Rosacea</keyword>
</DOC>